Benzinga | Nov 12, 2020 04:23PM EST

NovaBay Pharmaceuticals Q3 EPS $(0.08) Misses $(0.04) Estimate, Sales $2.17M Miss $2.52M Estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.04) by 100 percent. This is a 300 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $2.17 million which missed the analyst consensus estimate of $2.52 million by 13.89 percent. This is a 34.37 percent increase over sales of $1.61 million the same period last year.